Stock Events

Stock Events

Qualigen Therapeutics 

$3.21
29
+$0.17+5.59% Tuesday 21:00

Statistics

Day High
3.34
Day Low
2.86
52W High
8.81
52W Low
1.61
Volume
368,768
Avg. Volume
2,630,217
Mkt Cap
16.56M
P/E Ratio
0.45
Dividend Yield
-
Dividend
-

Earnings

25FebExpected
Q1 2024
Q2 2024
Q3 2024
Q4 2024
Q2 2025
Q3 2025
Q4 2025
-4.68
-3.28
-1.87
-0.47
Expected EPS
N/A
Actual EPS
N/A

Financials

-Profit Margin
Unprofitable
2019
2020
2021
2022
2023
2024
0Revenue
-12.12MNet Income

People Also Follow

This list is based on the watchlists of people on Stock Events who follow QLGN. It's not an investment recommendation.
Alphabet
79493
GOOGL
Apple
69146
AAPL
Microsoft
64576
MSFT
Amazon
60260
AMZN

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.
Gilead Sciences
GILD
Mkt Cap148.78B
Gilead Sciences is a biopharmaceutical company that competes in the development of therapeutics in areas similar to Qualigen, such as viral diseases, making it a direct competitor.
AMGEN
AMGN
Mkt Cap160.66B
Amgen is a biotech firm focusing on human therapeutics, including treatments for illnesses that Qualigen also targets, positioning it as a competitor.
Bristol-Myers Squibb
BMY
Mkt Cap93.79B
Bristol Myers Squibb operates in the biopharmaceutical field, developing prescription drugs that overlap with Qualigen's therapeutic areas.
Pfizer
PFE
Mkt Cap140.15B
Pfizer is a global pharmaceutical corporation with a broad product portfolio that includes treatments in areas competing with Qualigen's focus.
Merck
MRK
Mkt Cap214.76B
Merck & Co. is known for its innovative medicines and vaccines, some of which directly compete with Qualigen's product pipeline.
Abbvie
ABBV
Mkt Cap385.18B
AbbVie is a research-based biopharmaceutical company with a strong emphasis on developing innovative therapies, including those in competition with Qualigen.
Regeneron Pharmaceuticals
REGN
Mkt Cap68.5B
Regeneron Pharmaceuticals specializes in the discovery, development, and commercialization of medicines for serious conditions, competing with Qualigen's therapeutic areas.
Vertex Pharmaceuticals
VRTX
Mkt Cap109.11B
Vertex Pharmaceuticals is focused on creating new possibilities in medicine to cure diseases and improve people's lives, including areas where Qualigen operates.
Novartis
NVS
Mkt Cap237.61B
Novartis is a global healthcare company that provides solutions to address the evolving needs of patients worldwide, including in sectors where Qualigen is active.
Astrazeneca
AZN
Mkt Cap256.58B
AstraZeneca is a multinational pharmaceutical and biopharmaceutical company with a wide range of medical therapies that compete with Qualigen's developments.

About

Qualigen Therapeutics, Inc., a biotechnology company, develops novel therapeutic products for the treatment of cancer and infectious diseases. It offers FastPack, a rapid diagnostic testing system. The company is developing QN-302 for the treatment of pancreatic ductal adenocarcinoma; QN-247, a DNA coated gold nanoparticle cancer drug candidate that targets various cancers; RAS-F, a small-molecule RAS oncogene protein-protein inhibitor that blocks RAS mutations and inhibits tumor formation; and STARS blood cleansing system, a DNA/RNA-based treatment device that removes tumor-produced compounds and viruses from a patient's blood. Qualigen Therapeutics, Inc. was founded in 1996 and is based in Carlsbad, California.
Show more...
CEO
Mr. Kevin A. Richardson II
Employees
4
Country
US
ISIN
US74754R1032

Listings

F
DE
7R90.F
XNAS
US
AIXC
BOATS
BOATS
AIXC.BOATS

0 Comments

Share your thoughts

FAQ

What is Qualigen Therapeutics stock price today?▼
The current price of QLGN is $3.21 USD — it has increased by +5.59% in the past 24 hours. Watch Qualigen Therapeutics stock price performance more closely on the chart.
What is Qualigen Therapeutics stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on exchange Qualigen Therapeutics stocks are traded under the ticker QLGN.
Is Qualigen Therapeutics stock price growing?▼
QLGN stock has risen by +0% compared to the previous week, the month change is a +0% rise, over the last year Qualigen Therapeutics has showed a -5.87% decrease.
What is Qualigen Therapeutics market cap?▼
Today Qualigen Therapeutics has the market capitalization of 16.56M
What is Qualigen Therapeutics revenue for the last year?▼
Qualigen Therapeutics revenue for the last year amounts to 0 USD.
What is Qualigen Therapeutics net income for the last year?▼
QLGN net income for the last year is -12.12M USD.
How many employees does Qualigen Therapeutics have?▼
As of April 02, 2026, the company has 4 employees.
In which sector is Qualigen Therapeutics located?▼
Qualigen Therapeutics operates in the Health Care sector.
When did Qualigen Therapeutics complete a stock split?▼
The last stock split for Qualigen Therapeutics was on November 05, 2024 with a ratio of 1:50.
Where is Qualigen Therapeutics headquartered?▼
Qualigen Therapeutics is headquartered in Carlsbad, US.